540 results on '"Pays, Etienne"'
Search Results
2. The Mechanism of Kidney Disease due to APOL1 Risk Variants
3. Apolipoproteins L1 and L3 control mitochondrial membrane dynamics
4. The Two Levels of Podocyte Dysfunctions Induced by Apolipoprotein L1 Risk Variants
5. Distinct APOL1 functions in trypanosomes and kidney podocytes
6. The Trypanosoma Brucei KIFC1 Kinesin Ensures the Fast Antibody Clearance Required for Parasite Infectivity
7. Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes
8. The GPI-Phospholipase C of Trypanosoma brucei Is Nonessential but Influences Parasitemia in Mice
9. Specific Uptake of Tumor Necrosis Factor-α Is Involved in Growth Control of Trypanosoma brucei
10. APOLs with low pH dependence can kill all African trypanosomes
11. The Pathogenesis of African Trypanosomiasis
12. Apolipoproteins L1 and L3 Control Mitochondrial Membrane Dynamics
13. African trypanosome control in the insect vector and mammalian host
14. Transcription is initiated on silent variant surface glycoprotein expression sites despite monoallelic expression in Trypanosoma brucei
15. Endocytosis in African Trypanosomes
16. Adenylate Cyclases of Trypanosoma brucei Inhibit the Innate Immune Response of the Host
17. The function of apolipoproteins L (APOLs): relevance for kidney disease, neurotransmission disorders, cancer and viral infection
18. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
19. Identification of a Parasitic Immunomodulatory Protein Triggering the Development of Suppressive M1 Macrophages during African Trypanosomiasis
20. A Haptoglobin-Hemoglobin Receptor Conveys Innate Immunity to Trypanosoma brucei in Humans
21. Distinct Roles of Haptoglobin-Related Protein and Apolipoprotein L-I in Trypanolysis by Human Serum
22. Genetic and immunological basis of human African trypanosomiasis
23. P75 Tumor Necrosis Factor-Receptor Shedding Occurs as a Protective Host Response during African Trypanosomiasis
24. Attenuation of Trypanosoma brucei Is Associated with Reduced Immunosuppression and Concomitant Production of Th2 Lymphokines
25. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus
26. Human innate immunity against African trypanosomes
27. Double-Stranded RNA in Chromatin Transcripts Formed by Exogenous RNA Polymerase
28. Mechanism of Trypanosoma brucei gambiense resistance to human serum
29. Identification of Trypanosoma brucei components involved in trypanolysis by normal human serum
30. Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I
31. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
32. APOL1 variant–associated kidney disease: from trypanosomes to podocyte cytoskeleton
33. Apolipoprotein L-I is the trypanosome lytic factor of human serum
34. Cytokinesis of Trypanosoma brucei bloodstream forms depends on expression of adenylyl cyclases of the ESAG4 or ESAG4-like subfamily
35. The Mechanism of Kidney Disease Due to APOL1 Risk Variants
36. Multiparametric Atomic Force Microscopy Identifies Multiple Structural and Physical Heterogeneities on the Surface of Trypanosoma brucei
37. APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin
38. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill
39. Regulation of antigen gene expression in Trypanosoma brucei
40. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense
41. Identification and characterization of two trypanosome TFIIS proteins exhibiting particular domain architectures and differential nuclear localizations
42. Could cholesterol hold the key to defeating sleeping sickness?
43. Characterization of a TFIIH homologue from Trypanosoma brucei
44. Brief Report: Human Trypanosoma evansi Infection Linked to a Lack of Apolipoprotein L-I
45. Specific uptake of tumor necrosis factor-alpha is involved in growth control of Trypanosoma brucei
46. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness
47. Loss of the mono-allelic control of the VSG expression sites during the development of Trypanosoma brucei in the bloodstream
48. Control of gene expression in trypanosomes
49. A novel heterodimeric transferrin receptor encoded by a pair of VSG expression site-associated genes in T. brucei
50. Genetic controls for the expression of surface antigens in African trypanosomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.